Doubling Down After ATAI’s (ATAI) Anti Depression Treatment Bombs in Front of FDA.
Both a bad day and a Good day for Psychedelics. The Psychedelic Sector Holds Firm.
Atai was founded in...
Ouch, for Now. Progressive Care Does 200:1 Reverse.
MASSIVE REVERSE SPLIT
Let's just watch from the sidelines for...
He Shoots And He Scores. Ardelyx (ARDX) Gains 78%. Happy New Year!
Ah yes, and Gains Come to the Patient, as the FDA Moves the Ardelyx Ball Further Along.
Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis
SPU-21 effective in controlling arthritis progression.
SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide
Ardelyx (ARDX). Don’t be Nervous, It’s Just Money.
The Higher it Goes, The More Nervous we Get.
LIVE QUOTE
FDA to Ardelyx: “Give us a Couple More Weeks.” (ARDX) $1.80.
Oh boy, another day, another snag. There goes our Christmas bonus, dang.
LIVE QUOTE
It's been...
Can Lightning Strike Twice? Mitesco (MITI, MITID) Health Clinics.
Mitesco one of our Past Clients, Gained 10-Fold After we Added it to the Watch List, Just did a Reverse Split...
Adding Unicycive (UNCY) $0.75 to the Watch List.
Similar to Ardlyx (ARDX) which we added to the Watch List last week, Unicycive (no we don't know how they pronounce it) which will call UNCY - is...
Adding Silo Pharma (SILO) $3.50 to Watch List.
Look What We Found!
We launched the Psychedelic Stock Review a little more than a year ago and decided...
Silo Pharma (SILO) Issues Letter to Shareholders
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine
LIVE...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
